TrialDiabetes, obesity & metabolism2018
Ertugliflozin plus sitagliptin versus either individual agent over 52 weeks in patients with type 2 diabetes mellitus inadequately controlled with metformin: The VERTIS FACTORIAL randomized trial.
Richard E Pratley et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
90 papers cite itlatest 60 shown
this paperpooled ittrialcites it